NCT06508788 Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients
| NCT ID | NCT06508788 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitari de Bellvitge |
| Condition | Genitourinary Syndrome of Menopause |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-07-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Vaginal laser together with the use of moisturizing and repairing gels could be an effective therapy for the treatment of genitourinary syndrome in women with a history of neoplasia in whom the use of estrogens is not recommended. The purpose of this study is to evaluate the effectiveness of vaginal laser together with adjuvant treatment with a hydrating and repairing niosomal gel as a beneficial treatment in this group of patients.
Eligibility Criteria
Inclusion Criteria: * Patients with an established SGM diagnosis. * Patients with a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended. Exclusion Criteria: * Patients with concomitant vulvovaginal pathology. * Patients with a diagnosis of pelvic organ prolapse grade II or greater.
Frequently Asked Questions
Who can join the NCT06508788 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Genitourinary Syndrome of Menopause. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06508788 currently recruiting?
Yes, NCT06508788 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hospital Universitari de Bellvitge to inquire about joining.
Where is the NCT06508788 trial being conducted?
This trial is being conducted at L'Hospitalet de Llobregat, Spain.
Who is sponsoring the NCT06508788 clinical trial?
NCT06508788 is sponsored by Hospital Universitari de Bellvitge. The trial plans to enroll 30 participants.